2007•Unpublished venueRequires access

Toxicogenomics in Preclinical Development

Eric A.G. Blomme, Dimitri Semizarov, Jeffrey F. Waring

Abstract

This chapter contains sections titled: Introduction Practical and Logistic Aspects of Toxicogenomics Toxicogenomic Reference Databases Toxicogenomics in Drug Discovery In Vitro Toxicogenomics Toxicogenomics in Mechanistic Toxicology Toxicogenomics and Target - Related Toxicity Toxicogenomics and Idiosyncratic Toxicity Toxicogenomics in Regulatory Submissions Conclusion References

About this research paper

What this paper is about

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Toxicogenomics, Computational biology, Biology, Toxicology, Bioinformatics, Genetics, Gene, Gene expression